Search
Home
8
Course Catalog
4
Surgery Resources
2
ConnectEd for Patients
Course Catalog
Chemotherapy Resources
Coding Webinars
Core Lecture Series
Sentinel Paper Resource
SGO Meetings
Surgical Education
Trending Topics
Additional SGO Resources
Surgery Resources
Core Lecture Series Videos
ERAs (Enhanced Recovery After Surgery)
SGO Annual Meeting Films
SGO Robotics Academy
ConnectEd for Patients
On-Demand Courses (free)
Foundation for Women's Cancer Website
Jump to content
SGO ConnectEd
Search
Open menu
Cart
SGO ConnectEd login
Bookmark/Search this post
Facebook
Twitter
LinkedIn
Forward
Home
Course Catalog
Chemotherapy Resources
Coding Webinars
Core Lecture Series
Sentinel Paper Resource
SGO Meetings
Surgical Education
Trending Topics
Additional SGO Resources
Surgery Resources
Core Lecture Series Videos
ERAs (Enhanced Recovery After Surgery)
SGO Annual Meeting Films
SGO Robotics Academy
ConnectEd for Patients
On-Demand Courses (free)
Foundation for Women's Cancer Website
You are here
Home
Search
Brain Metastasis Considerations in Gynecologic Oncology Patients
Clinical Guide for Administering Chemotherapy in Hemodialysis Patients
Chemo Subcommittee: Management of Chemotherapy Hypersensitivity Reactions & Desensitization One-pager
Management of Chemotherapy Hypersensitivity Reactions and Desensitization: An SGO Clinical Practice Statement
2021 Chemotherapy & Targeted Therapy Flash Cards
Ocular Toxicities with ADCs Companion Card
Treatment Related Cardiotoxicity: Review and Management Companion Card
Keeping up with the Chemos Series on Trastuzumab Deruxtecan ENHERTU®: Monitoring Between Cycles (Pt. 3)
Keeping up with the Chemos Series on Trastuzumab Deruxtecan ENHERTU®: Preparing to Give It (Pt. 1)
Keeping up with the Chemos Series on Trastuzumab Deruxtecan ENHERTU®: Administration (Pt. 2)
Chemotherapy & Targeted Therapies Flash Cards
On-Demand Webinar: HIPEC in Gynecologic Oncology: State of the science and a practical how to
Keeping Up with the Chemos: CDK4/6 Inhibitors - Preparing to Give It (Part 1)
Keeping Up With the Chemos: CDK4/6 Inhibitors - Administration (Part 2)
Molecular Target: Folate Receptor Alpha (FOLR1)
SGO Oncofertility Part 2: Risks of Premature Ovarian Failure
SGO Late Breaking: ASCO 2024
SGO Late Breaking: FDA Approvals (2024)
SGO Late Breaking: SGO 2024